Zobrazeno 1 - 10
of 119
pro vyhledávání: '"M. Gubin"'
Autor:
Shan He, Matthew M. Gubin, Hind Rafei, Rafet Basar, Merve Dede, Xianli Jiang, Qingnan Liang, Yukun Tan, Kunhee Kim, Maura L. Gillison, Katayoun Rezvani, Weiyi Peng, Cara Haymaker, Sharia Hernandez, Luisa M. Solis, Vakul Mohanty, Ken Chen
Publikováno v:
iScience, Vol 27, Iss 6, Pp 110096- (2024)
Summary: Recent developments in immunotherapy, including immune checkpoint blockade (ICB) and adoptive cell therapy (ACT), have encountered challenges such as immune-related adverse events and resistance, especially in solid tumors. To advance the fi
Externí odkaz:
https://doaj.org/article/857a54432adf43e68098a98661073bd8
Autor:
A. M. Gubin
Publikováno v:
Courier of Kutafin Moscow State Law University (MSAL)). :161-169
The regulation of integration processes at the interstate and international levels has common foundations and fundamental differences, taking into account the implemented forms and directions of economic integration. Integration law refers to the cla
Publikováno v:
Siriraj Medical Journal, Vol 69, Iss 6, Pp 398-411 (2017)
Leishmaniasis is a parasitic disease caused by flagellated protozoa of the genus Leishmania. It is transmitted by infection from the bite of an infected sandfly. The 3 main clinical forms of the disease are cutaneous leishmaniasis (CL), visceral le
Externí odkaz:
https://doaj.org/article/cde05914d8e748a293084419eaf9fc6b
Autor:
Matthew M. Gubin, Brian T. Edelson, Ken Chen, Reshma Taneja, Josué E. Pineda, Anna M. Highsmith, Jeffrey P. Ward, Charmelle D. Williams, Ekaterina Esaulova, Sunita Keshari, Nicholas N. Jarjour, Qi Miao, Alexander S. Shavkunov, Avery J. Salmon
Immune checkpoint therapy (ICT) using antibody blockade of programmed cell death protein 1 (PD-1) or cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) can provoke T cell–dependent antitumor activity that generates durable clinical responses in s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76db012299fcae59fe721ea91357eaff
https://doi.org/10.1158/2326-6066.c.6550554.v1
https://doi.org/10.1158/2326-6066.c.6550554.v1
Autor:
Matthew M. Gubin, Brian T. Edelson, Ken Chen, Reshma Taneja, Josué E. Pineda, Anna M. Highsmith, Jeffrey P. Ward, Charmelle D. Williams, Ekaterina Esaulova, Sunita Keshari, Nicholas N. Jarjour, Qi Miao, Alexander S. Shavkunov, Avery J. Salmon
Supplementary Figure from BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eab028610fe4cfde3108c6638150e4c
https://doi.org/10.1158/2326-6066.22544160
https://doi.org/10.1158/2326-6066.22544160
Autor:
Robert D. Schreiber, Alan J. Korman, Elaine R. Mardis, Robert F. Graziano, Mark J. Selby, Jasreet Hundal, Sang Hun Lee, Cora D. Arthur, Matthew M. Gubin, Jeffrey P. Ward, Takuro Noguchi
Antibody blockade of programmed death-1 (PD-1) or its ligand, PD-L1, has led to unprecedented therapeutic responses in certain tumor-bearing individuals, but PD-L1 expression's prognostic value in stratifying cancer patients for such treatment remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::499ace0d0a9694d639e0c27216094086
https://doi.org/10.1158/2326-6066.c.6548426.v1
https://doi.org/10.1158/2326-6066.c.6548426.v1
Autor:
Robert D. Schreiber, Alan J. Korman, Elaine R. Mardis, Robert F. Graziano, Mark J. Selby, Jasreet Hundal, Sang Hun Lee, Cora D. Arthur, Matthew M. Gubin, Jeffrey P. Ward, Takuro Noguchi
Supplementary Figure S1. Genomic sequence of the PD-L1 locus and expression of immunogenic neoantigens in T3deltaPDL1 lines. Supplementary Figure S2. Expression of PD-L1 and neoantigens in the escape T3deltaPDL1 cells. Supplementary Figure S3. PD-L1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93ac53f562615ebe64dd48e6852f54cc
https://doi.org/10.1158/2326-6066.22537385
https://doi.org/10.1158/2326-6066.22537385
Autor:
Robert D. Schreiber, Alan J. Korman, Elaine R. Mardis, Robert F. Graziano, Mark J. Selby, Jasreet Hundal, Sang Hun Lee, Cora D. Arthur, Matthew M. Gubin, Jeffrey P. Ward, Takuro Noguchi
Supplementary Table S1. Staining panels for comprehensive analysis of cell types expressing PD-L1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b0dc312d0b2cfedc7c3cb109f24cc8
https://doi.org/10.1158/2326-6066.22537382.v1
https://doi.org/10.1158/2326-6066.22537382.v1
Autor:
Robert D. Schreiber, Alan J. Korman, Elaine R. Mardis, Robert F. Graziano, Mark J. Selby, Jasreet Hundal, Sang Hun Lee, Cora D. Arthur, Matthew M. Gubin, Jeffrey P. Ward, Takuro Noguchi
Figure Legends for Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::395d2fd12c36600805b28fee00d158ae
https://doi.org/10.1158/2326-6066.22537388.v1
https://doi.org/10.1158/2326-6066.22537388.v1
Autor:
M. Fehlings, Y. Simoni, H. L. Penny, E. Becht, C. Y. Loh, M. M. Gubin, J. P. Ward, S. C. Wong, R. D. Schreiber, E. W. Newell
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-12 (2017)
Immune checkpoint blockade (ICB) therapies can unleash anti-tumour T-cell responses. Here the authors show, by integrating MHC tetramer multiplexing, mass cytometry and high-dimensional analyses, that neoantigen-specific, tumour-infiltrating T cells
Externí odkaz:
https://doaj.org/article/7858136795e54c05b2eaf80fa3fc40f9